Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03763032 · ClinicalTrials.gov registry record · NA

Psychosocial Intervention in Latino Patients with Advanced Cancer

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT03763032: Completed NA study, sponsored by University of Colorado, Denver.

NCT03763032 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03763032, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

Palliative Care focuses on symptom management and quality of life and helps patients with life-limiting illness match goals and preferences for care. While there has been interest in and acknowledgement that palliative care is an important part of training patient navigators, there have been no previous studies examining the effectiveness of a navigation intervention to improve palliative care for patients. This study will examine the feasibility to implement patient navigator and psychosocial interventions.

Primary Outcome

Assess how likely patients are to join the study through tracking the number of patients that are eligible to participate.

Interventions

  • BEHAVIORAL Counseling

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2018-01-23
Est. Completion 2018-11-29
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT03763032 record still lists

NCT03763032 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Counseling is the first listed.

NCT03763032 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03763032 about?

NCT03763032 is a clinical study titled "Psychosocial Intervention in Latino Patients with Advanced Cancer". Palliative Care focuses on symptom management and quality of life and helps patients with life-limiting illness match goals and preferences for care. While there has been interest in and acknowledgement that palliative care is an important part of training patient navigators, there have been no prev...

What is the current status of trial NCT03763032?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-01-23. Estimated completion is 2018-11-29.

What interventions are being tested in trial NCT03763032?

The interventions under investigation include: Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT03763032?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03763032's enrollment target sits among peer trials

14 1909th of 2000 higher than 90 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT03763032, the US trial registry maintained by the National Library of Medicine. NCT03763032 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.